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Abstract  Microcirculation  imaging  in  breast  cancer  involves  studying  tissue  enhancement
after contrast  injection,  which  is  used  to  calculate  perfusion  and  permeability.  The  magnitude
of enhancement  reﬂects  blood  and  interstitial  volumes.  This  technique  has  beneﬁtted  from
advances in  MRI,  which  allow  large  volumes  to  be  acquired  with  a  good  compromise  between
temporal and  spatial  resolution.  Software  has  also  advanced  enabling  microcirculation  maps  to
be calculated  and  heterogeneity  to  be  analyzed.  If  permeability  is  increased  and  interstitial
volume is  reduced,  the  microcirculation  imaging  suggests  a  suspicious  aggressive  lesion  and  can
be used  for  early  assessment  of  neoadjuvant  therapies  by  demonstrating  restoration  of  normal
functional indices,  which  precede  morphological  changes.
© 2013  Published  by  Elsevier  Masson  SAS  on  behalf  of  the  Éditions  françaises  de  radiologie.
Aggressive  tumors  have  a  high  angiogenic  activity  which  helps  to  maintain  adequate
metabolic  resources  for  the  proliferating  cells.  Angiogenesis  is  a  series  of  processes  which
leads  to  proliferation  following  simulation  of  quiescent  endothelial  cells.  This  stimulation
leads  to  deterioration  in  the  basal  membrane  followed  by  neovascularization.
Angiogenesis  can  be  examined  histologically  by  measuring  the  microvascular  density
(MVD).  A  high  MVD  is  reported  to  be  a  positive  prognostic  indicator  in  patients  treated
with  adjuvant  chemotherapy  [1].  However,  the  abnormalities  seen  in  tumor  angiogenesis
are  not  restricted  just  to  an  increase  in  MVD,  as  morphological  and  functional  changes
are  also  seen  with  heterogeneous  distribution  of  the  microcirculation  and  hyperpermeable
microvessels.  Histologists  also  ﬁnd  arteriovenous  shunts  and  disparities  in  vessel  diameter.
In  addition,  blood  ﬂows  are  unstable  and  reversible  due  to  changes  in  interstitial  pressure
within  the  tumor.
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The  purposes  of  dynamic  imaging  are  to  measure  func-
ional  abnormalities  of  the  tumor  microcirculation  and  to
eﬁne  morphological  ﬁndings  in  order  to  characterize  a
umor  and  monitor  treatments.
echniques
ndices measured
he  breast  microcirculation  can  be  characterized  on  imag-
ng  by  measuring  four  conventional  indices:  tissue  perfusion,
apillary  permeability,  the  plasma  volume  fraction  and  the
nterstitial  volume  fraction.  Other  indices  described  in  the
iterature  are  calculated  from  these  four  basic  parame-
ers:  permeability  can  be  expressed  as  the  transfer  rate  kep
min−1)  which  is  represented  by  the  Ktrans/Ve ratio.  kep val-
es  generally  range  between  0.30  and  0.90  min−1.  The  mean
ransit  time  (MTT)  which  is  the  mean  time  taken  by  the
racer  to  cross  a  tumor  is  estimated  from  the  Vp/F  ratio.
he  MTT  ranges  between  20  and  60  seconds.
cquisition technique
unctional  imaging  of  tumor  microcirculation  is  based  on  an
nalysis  of  enhancement  of  the  MRI  signal  from  the  biological
istribution  of  a  contrast  medium  (gadolinium  chelate)  in
he  microvasculature  and  interstitial  tissue  of  the  lesion.
o  do  this,  the  tissue  enhancement  kinetics  are  examined
ynamically  and  measured  for  several  minutes  after  contrast
njection  taking  account  of  enhancement  kinetics  within  the
rteries  (Dynamic  Contrast  Enhancement  or  DCE)  (Fig.  1).
Perfusion  studies  require  a  very  high  image  rate  during
he  acquisition  (temporal  resolution  in  the  region  of  one
mage  per  second)  which  is  difﬁcult  to  achieve  practically  in
igure 1. Measurement of enhancement curves. Several acquisi-
ions covering the whole breast are taken at different time after
ntravenous contrast injection. A region of interest is drawn on the
esions each time, allowing signal intensities to be measured and an
nhancement-time curve to be constructed.
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sual  senology  practice.  Current  recommendations  are  that
patial  resolution  should  be  optimized,  working  with  pixels
nder  a  millimeter  in  size.  On  the  other  hand,  permeability
an  be  analyzed  with  temporal  resolution  of  one  image  every
0  to  30  seconds  and  spatial  resolution  of  under  a  millimeter
nd  can  therefore  be  incorporated  into  a  clinical  breast  MRI
rotocol  [2]  (Fig.  2).
Mathematical  models  such  as  those  described  by  Tofts
3],  Brasch  [4]  or  Lawrence  [5],  can  be  used  to  measure
he  tumor  angiogenesis  indices  from  enhancement  curves.
he  number  of  indices  measured  depends  on  the  choice  of
athematical  model  and  the  temporal  resolution.
The  Tofts  model  is  adapted  to  the  temporal  resolution
sed  routinely  in  breast  MRI  (1  image/30  seconds)  and  can  be
sed  to  measure  capillary  permeability  (Ktrans and  kep)  and
he  interstitial  volume  fraction  (Ve).  In  this  model,  tumor
nhancement  is  deemed  only  to  depend  on  the  content  of
he  interstitial  compartment,  the  contribution  from  the  cap-
llary  compartment  being  ignored  (Fig.  3).  Conversely,  the
ofts  model  to  analyze  data  obtained  under  high  temporal
esolution  (under  2  seconds)  leads  to  an  overestimate  of  per-
eability  (of  over  50%).  Enhancement  due  to  contrast  in
he  capillaries  is  clearly  visible  in  the  initial  phase  of  high
emporal  resolution.  The  Tofts  model  assumes  that  capillary-
elated  enhancement  is  part  of  the  interstitial  enhancement
nd  includes  a ‘‘perfusion  dose’’  in  the  permeability  calcu-
ation  [2].
Analysis  of  tissue  perfusion  in  the  breast  is  complicated,
rstly  because  of  the  necessary  temporal  resolution  which  is
ncompatible  with  the  spatial  resolution  recommended  for
 reliable  morphological  analysis  [6]  and  secondly  by  prob-
ems  due  to  high  concentrations  of  contrast  in  the  blood
essels  and  tumors  in  the  initial  enhancement  phase  which
s  used  to  extract  the  perfusion  data.  High  concentrations  of
igure 2. Enhancement curve within the tumor. The initial
nhancement phase represents the arrival of contrast medium in
he tumor capillaries and reﬂects perfusion (F). Amplitude reﬂects
lood volume (Vp). Observation of this ﬁrst phase requires high
emporal resolution (1 image/second) and is still a research tool.
he second enhancement phase represents exchange of contrast
etween plasma and interstitium. The analysis of this second part
f the curve does not require any major change to clinical MRI
rotocols with low temporal resolution (1 image/30 s).
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Figure 3. A 45-year-old patient treated with neoadjuvant chemotherapy for inﬁltrating ductal carcinoma of the right breast, with locally
advanced disease. A, C and E before treatment; B, D and F at two cycles. Morphological analysis shows a partial response after two cycles
ft m
 a 75with a 50% reduction in lesion size. Functional analysis using the To
Mapping and histogram analysis show restoration of normal Ve, withgadolinium  chelate  outside  of  blood  cells  which  are  imper-
meable  to  contrast  create  magnetic  ﬁeld  heterogeneities
within  the  capillary  lumen,  causing  a  fall  in  signal  by  the  T2*
effect  [7].  On  T1-weighted  MR,  the  T2*  effect  is  seen  in  blood
v
a
o
kodel shows insigniﬁcant progression of the mean Ve values (+16%).
% fall in the number of abnormal pixels.essels  and  tumors  at  the  concentration  peak  immediately
fter  contrast  injection.  The  contrast  then  dilutes  through-
ut  the  whole  blood  volume  and  is  then  excreted  by  the
idneys.  The  T2*  effect  is  difﬁcult  to  correct  for  and  restricts
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he  capacity  to  calculate  perfusion  in  the  initial  phase  of  T1-
eighted  enhancement  kinetics  [8].  Some  authors  therefore
uggest  that  a  second  contrast  injection  be  given  and  that
nhancement  be  monitored  on  a  T2*-weighted  sequence.
n  T2*-weighting  (and  echo  planar  sequence),  the  arrival  of
ontrast  in  the  capillary  lumens  leads  to  a  fall  in  signal.  If
e  assume  that  the  capillary  wall  is  impermeable  to  the  low
olecular  weight  contrast,  perfusion  and  blood  volume  can
hen  be  calculated,  as  the  changes  in  signal  are  theoreti-
ally  due  to  the  contrast  contained  in  blood  vessels  [9,10].
n  breast  tumors,  however,  the  assumption  that  the  capillary
all  is  impermeable  is  not  valid  and  perfusion  measurements
rom  the  intravascular  component  can  be  incorrect  due  to
he  T1  effect  caused  by  contrast  medium  passing  into  the
nterstitium,  which  reduces  the  fall  in  signal.
pplications
umor characterization
icrocirculation  studies  appear  to  be  useful  to  characterize
he  aggressive  nature  of  a  tumor.  Koo  et  al.  reported  that
apillary  permeability  (Ktrans and  kep)  increases  with  Scarff
nd  Bloom  SBR  grade  (Fig.  4)  [11].  The  kep index  is  reported
o  be  higher  in  triple  negative  tumors  than  in  hormone  recep-
or  and  HER2  positive  tumors  and  the  interstitial  volume
raction  Ve is  reported  to  be  lower  in  high-grade  tumors
SBR  III),  which  do  not  express  hormone  or  HER2  receptors.
hese  histological  features  are  seen  in  aggressive  tumors  in
ssociation  with  high  cellular  proliferation  rates  (with  Ki67
verexpression).  The  fall  in  Ve is  explained  by  the  high  cell
ensity  in  these  tumors.
Breast  tumors  have  been  identiﬁed  from  the  level  of  mes-
enger  RNA  expression  and  classiﬁed  into  several  subgroups:
uch  as  luminal,  HER2  and  basal-like,  etc.  Immunohisto-
hemical  labeling  provides  a  simpliﬁed  approach  to  this
lassiﬁcation  for  use  in  clinical  practice  from  transcrip-
ome  data  [12].  The  proliferation  index  (Ki67),  expression
f  estrogen  (ER),  progesterone  (PR)  and  the  HER2  proto-
ncogene  receptors  are  good  practical  clinical  tools  to  make
n  approximation  [13].  Clinically,  therefore,  the  ‘luminal
’  (ER+  or  PR+,  low  Ki67  <  14%)  phenotype  is  deﬁned  and
s  associated  with  a  good  prognosis.  The  luminal  B’  phe-
otype  (ER+  or  PR+  and  high  Ki67  and/or  c-erb2+),  the
HER2’  phenotype  (ER−,  PR−  and  overexpressed  c-erb2)  and
he  ‘basal-like’  phenotype  (ER−,  PR−,  c-erb2−, high  Ki67,
K5/6+  and  EGFR+)  can  be  deﬁned.  These  latter  three  types
re  associated  with  a  poor  prognosis  than  the  ‘luminal  A’
ype  [13].  Microcirculatory  indices  appear  to  correlate  with
he  different  breast  cancer  subtypes  (Fig.  5).  Li  et  al.  have
hown  that  permeability  (kep)  was  increased  and  the  inter-
titial  volume  fraction  (Ve)  was  reduced  in  triple  negative
umors  compared  to  luminal  tumors  [10].  Levels  of  Vascular
ndothelial  Growth  Factor  (VEGF)  are  doubled  or  tripled  in
riple  negative  cancers  compared  to  luminal  cancers  par-
icularly  because  of  P53  mutations  which  deregulate  the
EGF  promoter  [14].  VEGF  activity  is  therefore  responsible
or  abnormal  structural  and  functional  hypervasculariza-
ion.  The  fall  in  MTT  is  believed  to  reﬂect  shunt  effects
n  triple  negative  tumors  and  the  high  kep to  be  due  to  a
EGF-induced  increase  in  permeability.  Huuse  et  al.  have
d
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lso  reported  that  Ktrans and  Vp correlate  with  microvascular
roliferation  (endothelial  cell  Ki67  and  CD-34  expression)
hich  is  increased  in  basal-like  compared  to  luminal
umors  [15].
MRI  is  the  best  technique  to  detect  inﬁltrating  lobu-
ar  carcinomas  (ILC),  which  are  amongst  the  most  difﬁcult
reast  tumors  to  identify.  We  have  shown  that  dynamic  MRI
an  show  differences  in  capillary  permeability  (Ktrans and  kep)
nd  interstitial  volume  fraction  (Ve) between  ILC  and  inﬁl-
rating  ductal  carcinomas  (IDC).  The  most  useful  indices  are
eported  to  be  the  Ve and  kep,  with  a  higher  Ve in  ILC  (47%
ompared  to  30%,  P  >  0.0001)  and  a  lower  kep (0.652  com-
ared  to  0.970,  P  <  0.0001).  The  histological  appearances  of
LC  in  our  study  were  superimposable  on  those  from  Arpino’s
tudy  [16],  with  the  majority  of  ILC  being  estrogen  receptor
ositive  and  HER2  negative.  These  features  show  that  the
LC  mostly  belong  to  the  luminal  subtype.  The  microcircula-
ory  functional  features  of  ILC  are  those  seen  in  the  luminal
ype  of  tumor  (Fig.  6).  On  the  other  hand,  the  ILC  behave
ar  more  aggressively  than  the  luminal  tumors  and  behave
ore  like  the  triple  negative  cancers.  The  microcirculation
herefore  does  not  appear  to  explain  the  far  poorer  progno-
is  of  the  ILC  [17].  These  results  could  help  us  to  understand
he  pathogenesis  and  treatment  of  ILC.
onitoring treatments
nthracycline  and  taxane  chemotherapies  have  anti-
ngiogenic  activity  similar  to  the  targeted  therapies
hich  reduce  the  number  of  microvessels  in  tumors  and
estore  normal  microvessel  architecture.  These  microscopic
hanges  are  accompanied  by  functional  changes,  with  a  fall
n  capillary  blood  ﬂow,  which  returns  to  being  unidirectional,
nd  a  reduction  in  the  permeability  of  the  capillary  wall.
hese  microcirculatory  changes  have  a  cytostatic  effect
hich  stops  tumor  progression.  Stabilization  of  tumor  vol-
me  in  response  to  angiogenesis  inhibitors  on  morphological
maging  can  therefore  be  considered  to  be  a good  response.
he  RECIST  criteria,  which  require  a  30%  or  greater  reduc-
ion  in  tumor  volume  to  conﬁrm  a partial  response,  do
ot  appear  to  apply  well  to  monitoring  these  new  treat-
ents.
Functional  microcirculatory  MRI  could  have  a  role  in  opti-
izing  the  assessment  of  breast  cancer  treatments.  It  may
lso  help  to  predict  response  after  neoadjuvant  chemother-
py  in  patients  being  followed  up  for  locally  advanced  breast
ancer.  Changes  in  microcirculatory  indices  precede  mor-
hological  changes  and  appear  even  to  be  more  sensitive  and
peciﬁc  [9,18]. Tumor  microcirculation  is  reported  to  begin
o  return  to  normal  from  the  sixth  week  of  treatment  in
atients  with  a  good  histological  response  after  surgery.  An
mprovement  of  50%  or  more  in  permeability,  blood  volume
nd  perfusion  appears  to  suggest  a  good  response.  Con-
ersely,  the  indices  tend  to  remain  stable  in  non-responders.
n  the  other  hand,  changes  in  size  on  MRI  at  6  weeks  do  not
istinguish  responders  from  non-responders  (Figs.  7  and  8).
ermeability  appears  to  be  the  best  functional  index  to  pre-
ict  a  poor  response,  achieving  a  sensitivity  of  90—94%  and
 speciﬁcity  of  80—83%  [9,18].  These  studies,  however,  were
arried  out  on  small  patient  numbers  and  larger  studies  are
waited.
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t with
lume
hFigure 4. Comparison of microcirculation indices and histologic
I) inﬁltrating ductal carcinoma (IDC). B, D, F: a 58-year-old patien
permeability within the tumor increases and that the interstitial vo
DiscussionMicrocirculation  imaging  can  add  further  supporting  evi-
dence  for  suspicious  aggressive  lesion.  Increased  permeabil-
ity  and  reduced  interstitial  volume  suggest  that  the  lesion  is
t
e
i
mR grade, A, C, E: a 55-year-old patient seen with low-grade (SBR
 high-grade IDC (SBR III). These examples illustrate that capillary
 fraction is reduced in high-grade compared to low-grade lesions.
igh  grade  and  does  not  overexpress  hormone  or  HER2  recep-
ors.  Studying  the  microcirculation  can  also  be  used  in  the
arly  assessment  of  neoadjuvant  therapies  by  demonstrat-
ng  restoration  of  normal  functional  indices,  which  precedes
orphological  changes.
1284  C.  de  Bazelaire  et  al.
Figure 5. Comparison of microcirculation indices and tumor phenotype. A, C and E: an 83-year-old patient with luminal A subtype
inﬁltrating ductal carcinoma (IDC) (RE+, RP−,  HER2− and negative Ki67). B, D and F: a 70-year-old patient with a triple negative subtype
I llary 
v he lu
K
i
wDC (RE−, RP−,  HER2−, Ki67+). These examples illustrate that capi
olume fraction is reduced in triple negative lesions compared to tThe  results  published  for  some  indices  such  as  the
trans vary  [11,19].  All  contrast  media  used  in  routine  clin-
cal  practice  contain  small  gadolinium  chelate  molecules
hich  circulate  in  the  capillary  lumen  and  cross  their
w
a
f
tpermeability within the tumor is increased whereas the interstitial
minal A subtype.alls.  Enhancement  therefore  reﬂects  both  permeability
nd  perfusion.  Ktrans therefore  depends  on  changes  in  per-
usion  due  to  blood  pressure  and  heart  rate  unrelated  to
he  tumor  microcirculation.  On  the  other  hand,  kep only
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Figure 6. Comparison of its microcirculation indices and histological type. A, C and E: an 83-year-old patient with inﬁltrating lobular
ducta
o tho
ocarcinoma (ILC). B, D and F: a 48-year-old patient with inﬁltrating 
within the tumor and the interstitial volume of the ILC are similar t
reﬂects  capillary  permeability  and  appears  to  be  more
robust  [11].
Functional  tissue  heterogeneity  can  be  displayed  on  his-
tograms  used  to  quantify  the  magnitude  of  abnormal  areas
and  their  change  over  time.  The  methods  available  to
a
i
a
tl carcinoma (RE+, RP+, HER2− and Ki67−). Capillary permeability
se in the luminal A IDC.
bjectively  compare  these  histograms  however  are  limited
nd  are  generally  not  available  in  microcirculation  analyt-
cal  software.  The  available  software  also  does  not  enable
n  analysis  to  be  made  of  parametric  images  to  assess  spa-
ial  heterogeneity,  whereas  a  heterogeneous  microvascular
1286  C.  de  Bazelaire  et  al.
Figure 7. Early assessment (two cycles) of the effectiveness of neoadjuvant chemotherapy on an IDC of the left breast. A, C and E: before
chemotherapy. B, D and F: after two cycles. Comparison of size and microcirculatory indices before and after two cycles shows an 80% fall
i abili
i hemo
d
t
b
an tumor size. Microcirculation analysis shows that capillary perme
ncreased by 40%. Analysis of the surgical specimen at the end of cistribution  is  one  of  the  criteria  for  identifying  malignant
umors.  Functional  heterogeneity  analytical  modules  for
reast  cancer  incorporated  into  functional  imaging  software
re  therefore  awaited  with  anticipation!
a
s
ity has fallen by 99% and that the interstitial volume fraction has
therapy shows a complete response (Sataloff A).The  performance  of  microcirculation  analysis  is  gener-
lly  compared  to  morphological  ﬁndings.  Numerous  breast
tudies  have  shown  that  changes  in  microcirculatory
ndices  precede  changes  in  tumor  size  [9,20].  Whilst  the
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Figure 8. Early assessment (two cycles) of the effectiveness of neoadjuvant chemotherapy on an IDC of the right breast. A, C and E:
before chemotherapy. B, D and F: after two cycles. A comparison of size and microcirculatory parameters before and after two  cycles shows
a 70% fall in tumor size. However, microcirculation analysis shows that capillary permeability was initially low and that it has not fallen on
les. Atreatment. The interstitial volume fraction is also stable at two cyc
a histological response of under 50% (Sataloff C).combined  use  of  morphological  and  functional  criteria  could
improve  diagnostic  performance  [21],  the  examination  is  sig-
niﬁcantly  prolonged  in  order  to  obtain  morphological  data  (5
to  10  minutes),  diffusion  measurements  (2  to  5  minutes)  and
a
c
analysis of the surgical specimen at the end of chemotherapy showscquisition  of  enhancement  kinetics  to  analyze  the  micro-
irculation  (10  to  15  minutes).
Various  more  or  less  sophisticated  mathematical  models
re  now  available  (such  as  Tofts,  Brasch  and  Sir  Laurence),
1w
c
r
T
a
f
(
t
o
s
t
l
r
c
l
T
v
b
t
C
A
C
c
u
s
i
o
a
m
i
C
T
d
i
a
Q
1
e
(
(
t
c
(288  
hich  have  clearly  deﬁned  application  conditions.  The  main
riteria  used  to  decide  on  the  choice  of  model  are  tempo-
al  resolution,  type  of  tracer  and  anatomical  conditions.
he  choice  of  temporal  resolution  used  depends  on  the
natomical  volume  being  examined:  a  staging  assessment
or  breast  cancer  requires  a  large  volume  to  be  examined
a  3D  study  covering  both  breasts),  in  high  spatial  resolu-
ion  in  order  to  identify  the  morphological  details  suggestive
f  malignant  disease  such  as  spicules  under  a  millimeter  in
ize  [6,22].  This  type  of  analysis  restricts  temporal  resolu-
ion  (one  acquisition  per  minute).  A  clearly  identiﬁed  target
esion  can  be  monitored  on  treatment  under  high  tempo-
al  resolution  (1  image/second)  by  covering  a  small  volume
entered  on  the  lesion  (often  a  2D  study)  [8].
Finally,  acquisition  and  techniques  and  software  to  ana-
yze  the  microcirculation  have  not  been  standardized  [23].
he  standardization  limitations  are  delaying  the  large-scale
alidation  of  microcirculation  analysis,  which  is  required
efore  these  techniques  pass  widely  into  routine  prac-
ice.
onclusion
ngiogenesis  imaging  can  improve  breast  MRI  performance.
linical  applications  are  developing  for  the  breast  as  in  the
olon,  prostate  and  liver.  Analysis  of  heterogeneity  and  the
se  of  additional  ﬁndings  such  as  change  in  tumor  volume
hould  improve  functional  imaging  performance.  Simplify-
ng  the  protocols  is  also  an  important  stage.  The  emergence
f  new  multichannel  aerials  should  accelerate  acquisitions
llowing  simultaneous  investigation  of  morphology  and  the
icrocirculation  with  high  temporal  and  spatial  resolution
n  the  same  investigation.
TAKE-HOME  MESSAGES
General  concepts
• All  of  the  microcirculatory  indices  (tissue  perfusion,
capillary  permeability,  blood  volume  and  interstitial
volume  fractions)  and  diffusion  and  spectroscopy  can
be  obtained  from  the  breast  using  dynamic  enhanced
MRI  to  analyze  cellularity.
• Good  practice,  however,  suggests  that  spatial
resolution  needs  to  be  optimized  with  pixels  under
a  millimeter  in  size;  the  breast  MRI  protocol  is
used  routinely,  prioritized  spatial  over  temporal
resolution  and  restricts  the  analysis  of  tumor
microcirculation  to  capillary  permeability  and
interstitial  volume  fraction. (C.  de  Bazelaire  et  al.
• Microcirculation  analysis  software  is  still  expensive
and  not  widely  available  in  breast  imaging
departments.
Main  results
• The  microcirculation  is  related  to  the  level  of
malignancy  in  breast  cancers.  Permeability  increases
and  the  interstitial  volume  fraction  falls  in  high-
grade  compared  to  low-grade  cancers.
• The  microcirculation  is  related  to  the  histological
features  of  the  tumor.  Permeability  increases  and  the
volume  fraction  falls  in  tumors,  which  do  not  have
hormone  or  HER2  receptors.
• The  microcirculation  also  depends  on  tumor  subtype
deﬁned  from  transcriptome  data  or  more  simply
obtained  from  immunohistochemical  ﬁndings.
Permeability  is  increased  and  the  interstitial  volume
fraction  is  reduced  in  the  ‘‘basal-like’’  subtypes
compared  to  the  luminal  subtypes.  These  ﬁndings
are  of  prognostic  use.
• Microcirculation  can  improve  the  reliability  of
MRI  to  assess  the  effectiveness  of  neoadjuvant
chemotherapy  by  demonstrating  restoration  of
normal  permeability  (lower)  and  volume  fraction
(higher)  early,  from  the  second  cycle  of  treatment
compared  to  pretreatment  (‘‘baseline’’)  values.
linical case
his  51-year-old  patient  is  being  seen  for  a  53  mm  inﬁltrating
uctal  carcinoma  (IDC)  in  her  left  breast.  The  tumor  is  an
rregular  mass  with  circumscribed  borders.  It  enhances  early
nd  intensely  followed  by  an  obvious  washout.
uestions
.  Based  on  the  ﬁndings  in  Fig.  9,  the  amplitude  of  the
nhancement  peak  indicates:
(a)  Low  capillary  permeability.
b)  High  capillary  permeability.
(c)  A  high  interstitial  volume  fraction.
d)  A  low  interstitial  volume  fraction.
2.  Fig.  10  shows  that  permeability  is  extremely  high  and
hat  the  interstitial  volume  fraction  is  normal  overall.  What
an  be  concluded  from  this?
(a)  The  tumor  is  probably  a  low  histological  grade  (SBR  I).
b)  The  tumor  is  probably  luminal.
(c)  The  tumor  is  progressing  rapidly.
d)  The  tumor  should  respond  well  to  neoadjuvant
chemotherapy  and  mastectomy  may  be  avoided.
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Figure 9. Mass in the superior external quadrant of the left breast (le
Figure 10. Permeability mapping within the tumor (Ktrans) and
K
e
t
D
T
c
Rtabulated summary of values (median, mean and standard devia-
tion) of Ktrans, kep, Ve and area under the enhancement curve.
Answers
1.  Correct  answer:  b.
The  amplitude  of  the  enhancement  peak  depends  mostly
on  perfusion,  blood  volume  and  permeability.  An  early
intense  enhancement  peak  indicates  that  one  of  these  three
microcirculatory  indices  is  increased.  It  is  not  possible  to  cal-
culate  the  interstitial  volume  fraction  from  the  qualitative
analysis  of  the  enhancement  peak.
2.  Correct  answer:  c.
High  capillary  permeability  and  a  normal  interstitial  vol-
ume  fraction  is  more  suggestive  of  a  high-grade  (SBR  III)
tumor  and  generally  a  triple  negative  tumor.  In  this  case,  theft) and tumor enhancement curve (right).
i67  marker  was  overexpressed  indicating  high  tumor  prolif-
ration.  Skin  invasion  is  a  contraindication  to  conservative
reatment  regardless  of  clinical  or  MRI  response.
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